[{"id":"1348b56a-d2c5-4a14-a97d-fa49a13065de","acronym":"","url":"https://clinicaltrials.gov/study/NCT04100187","created_at":"2021-01-18T20:03:32.798Z","updated_at":"2024-07-02T16:35:59.767Z","phase":"Phase 1","brief_title":"Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia","source_id_and_acronym":"NCT04100187","lead_sponsor":"Kecellitics Biotech Company Ltd","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e anti-CD19-CAR"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 02/01/2023","start_date":" 02/01/2023","primary_txt":" Primary completion: 08/01/2023","primary_completion_date":" 08/01/2023","study_txt":" Completion: 08/01/2024","study_completion_date":" 08/01/2024","last_update_posted":"2022-12-01"}]